Obesity
| Treatments
Obesity
Treatments
Insights on Tirzepatide from the SURMOUNT Trials
book_2
Source:
ObesityWeek 2023 - Session summary
calendar_today
Published on Medfyle:
November 2023
import_contacts
3
min
In this medfyle
With tirzepatide, female sex, lower baseline body weight and lower baseline HbA1c have all been associated with greater weight loss.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the ObesityWeek®️ 2023.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content.
©️2023 Infomedica-Medfyle. All rights reserved.
